Hoppa till innehållet
OMXsum
← Marknaden
Company updateSurgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ): Annual Report 2025

Kursreaktion
+43,3 %
Sedan publicering
RVOL vid samma tid
Saknas
18 sep.
RVOL mot heldag
0,4×
18 sep. · 20 dagars snitt

Aktiekurs

Mätpunkter & underlag

Aktien 18 sep.

Senaste kurs
49,2 SEK

18 sep. 17:30

Föregående stängning
48,28 SEK

2026-09-17

Handlad volym
94 233 aktier

18 sep. 17:29

Jämförelseunderlag
0 handelsdagar · preliminärt

18 sep. mot föregående stängning

+1,9 %

RVOL vid samma tid jämför den kumulativa volymen med samma klockslag tidigare handelsdagar. RVOL mot heldag jämför med snittet för 20 hela handelsdagar. Det är bolagets handel, inte volym orsakad av nyheten.

Handelsdagen ovan är senare än nyhetens första börssession.

Leverantörens stängningskurs; justering för bolagshändelser är inte verifierad.

Läs hela källtexten

Surgical Science has today published its Annual Report for 2025. The document is attached to this press release and is also available at www.surgicalscience.com. Printed copies are sent to shareholders who so request and state their postal address. Gothenburg, Sweden, April 15, 2026 Surgical Science Sweden AB (publ) The Annual Report is available in the attachment or via https://surgicalscience.com/investor-relations/#press-releases https://surgicalscience.com/aktien/financial-report (https://surgicalscience.com/investor-relations/#financial-report) For further information, please contact: ------------------------------------------------------------------------------ Tom Englund, CEO Telephone: +46-70-916 16 81 E-mail: tom.englund@surgicalscience.com Anna Ahlberg, CFO Telephone: +46-70-855 38 35 E-mail: anna.ahlberg@surgicalscience.com About Surgical Science Sweden AB (publ) ------------------------------------------------------------------------------ Surgical Science is a global leader in evidence-based medical simulation. The company’s virtual reality simulators and customized training solutions enable surgeons and healthcare professionals to practice and improve their skills outside the operating room - enhancing patient safety and clinical outcomes. Also, Surgical Science partners with medical technology and robotics companies to integrate tailor-made simulation technology into their devices, helping them accelerate innovation and gain a competitive edge. Surgical Science has approximately 310 employees. The company is headquartered in Gothenburg, Sweden, and has operations in Tel Aviv, Israel; Stockholm, Sweden; Cleveland, US; and Cardiff, UK. Through sales offices in these markets and in China, as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market, Stockholm, Sweden. Certified Adviser is DNB Carnegie Investment Bank AB. Attachments ------------------------------------------------------------------------------ SuS AR25 EN (https://storage.mfn.se/cdb09013-8d30-4cb7-bbac-6dc83723365a/sus-ar25-en.pdf)

Källor & underlag

Fortsätt till nyhetsflödet Dina bevakningar